» Articles » PMID: 8636949

Antibody Response in Rabbits to Serotype-specific Determinants in Lipopolysaccharides from Moraxella Catarrhalis

Overview
Journal J Med Microbiol
Specialty Microbiology
Date 1996 May 1
PMID 8636949
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Antibodies against the serotype determinant epitopes of Moraxella catarrhalis lipopolysaccharides (LPS) were demonstrated in sera from rabbits immunised with whole bacterial cells. Purified LPS preparations from eight strains of M. catarrhalis were used as antigens in enzyme-linked immunosorbent assays (ELISA) and immunoblotting. The serotype specificity of the antibodies was shown by neutralisation with LPS and with purified polysaccharide obtained from LPS prepared from strains belonging to different serotypes. In immunoblots, antisera against the A and B LPS serotypes reacted only with LPS of its own type, confirming the presence of type-specific antibodies. A weak band was observed with type A LPS and antibody to type C, indicating cross-reactivity between the A and C serotypes. This cross-reaction can be explained on the basis of the known chemical structure of the LPS of the different serotypes. After heterologous absorption of sera, bands were obtained with homologous LPS antigen. These results suggest that the predominant antibody response in rabbits to LPS from M. catarrhalis is serotype-specific, unlike that previously observed in infected human patients.

Citing Articles

Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.

Schwingel J, Edwards K, Cox A, Masoud H, Richards J, St Michael F Infect Immun. 2009; 77(10):4548-58.

PMID: 19651870 PMC: 2747917. DOI: 10.1128/IAI.00294-09.


Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.

Yu S, Xie H, Datta A, Naidu N, Gu X Infect Immun. 2008; 76(9):4251-8.

PMID: 18559429 PMC: 2519401. DOI: 10.1128/IAI.01570-07.


Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis.

Yu S, Gu X Infect Immun. 2007; 75(6):2974-80.

PMID: 17371852 PMC: 1932890. DOI: 10.1128/IAI.01915-06.


Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.

Gergova R, Iankov I, Haralambieva I, Mitov I Curr Microbiol. 2007; 54(2):85-90.

PMID: 17211546 DOI: 10.1007/s00284-005-0463-6.


Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.

Edwards K, Schwingel J, Datta A, Campagnari A J Clin Microbiol. 2005; 43(12):6139-43.

PMID: 16333114 PMC: 1317230. DOI: 10.1128/JCM.43.12.6139-6143.2005.